Literature DB >> 25135221

A novel β-catenin signaling pathway activated by IL-1β leads to the onset of epithelial-mesenchymal transition in breast cancer cells.

Eloy Andres Perez-Yepez1, Jorge-Tonatiuh Ayala-Sumuano2, Ruth Lezama3, Isaura Meza4.   

Abstract

Interleukin 1β has been associated with tumor development, invasiveness and metastasis in various types of cancer. However, the molecular mechanisms underlying this association have not been clearly elucidated. The present study is the first to show, in breast cancer cells, that an IL-1β/IL-1RI/β-catenin signaling pathway induces β-catenin accumulation due to GSK3β inactivation by Akt phosphorylation. Translocation to the nucleus of accumulated β-catenin and formation of the TCF/Lef/β-catenin complex induce sequential expression of c-MYC, CCDN1, SNAIL1 and MMP2, leading to up-regulation of proliferation, migration and invasion; all of the processes shown to be required, in cancerous cells, to initiate transition from a non-invading to an invasive phenotype.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer cell; IL-1RI/β-catenin signaling; IL-1β stimulation; Invasiveness

Mesh:

Substances:

Year:  2014        PMID: 25135221     DOI: 10.1016/j.canlet.2014.08.015

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  19 in total

Review 1.  The contrasting roles of inflammasomes in cancer.

Authors:  Qin He; Yu Fu; Dean Tian; Wei Yan
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

2.  Downstream Signaling of Inflammasome Pathway Affects Patients' Outcome in the Context of Distinct Molecular Breast Cancer Subtypes.

Authors:  Concetta Saponaro; Annarita Fanizzi; Margherita Sonnessa; Paolo Mondelli; Daniele Vergara; Donato Loisi; Raffaella Massafra; Agnese Latorre; Francesco A Zito; Laura Schirosi
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-24

Review 3.  Role of inflammasome activation in tumor immunity triggered by immune checkpoint blockers.

Authors:  M Segovia; S Russo; M R Girotti; G A Rabinovich; M Hill
Journal:  Clin Exp Immunol       Date:  2020-05       Impact factor: 4.330

4.  Family Study Designs Informed by Tumor Heterogeneity and Multi-Cancer Pleiotropies: The Power of the Utah Population Database.

Authors:  Heidi A Hanson; Claire L Leiser; Michael J Madsen; John Gardner; Stacey Knight; Melissa Cessna; Carol Sweeney; Jennifer A Doherty; Ken R Smith; Philip S Bernard; Nicola J Camp
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-02-25       Impact factor: 4.254

5.  NLRP3 inflammasome activation plays a carcinogenic role through effector cytokine IL-18 in lymphoma.

Authors:  Xia Zhao; Chen Zhang; Mingqiang Hua; Ruiqing Wang; Chaoqin Zhong; Jie Yu; Fengjiao Han; Na He; Yanan Zhao; Guoqiang Liu; Ni Zheng; Chunyan Ji; Daoxin Ma
Journal:  Oncotarget       Date:  2017-09-18

6.  Importance of CD200 expression by tumor or host cells to regulation of immunotherapy in a mouse breast cancer model.

Authors:  Anna Curry; Ismat Khatri; Olha Kos; Fang Zhu; Reginald Gorczynski
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

7.  bFGF promotes neurological recovery from neonatal hypoxic-ischemic encephalopathy by IL-1β signaling pathway-mediated axon regeneration.

Authors:  Zheng Ma; Fang Wang; Lu-Lu Xue; Ying-Jie Niu; Yue Hu; Zhang-Yu Su; Jin Huang; Rui-Ze Niu; Ting-Hua Wang; Ying-Chun Ba; Liu-Lin Xiong; Xue Bai
Journal:  Brain Behav       Date:  2020-06-11       Impact factor: 2.708

Review 8.  The Role of Inflammation in Breast and Prostate Cancer Metastasis to Bone.

Authors:  Andy Göbel; Stefania Dell'Endice; Nikolai Jaschke; Sophie Pählig; Amna Shahid; Lorenz C Hofbauer; Tilman D Rachner
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

9.  A niche that triggers aggressiveness within BRCA1-IRIS overexpressing triple negative tumors is supported by reciprocal interactions with the microenvironment.

Authors:  Daniel Ryan; Abhilasha Sinha; Danielle Bogan; Joanna Davies; Jim Koziol; Wael M ElShamy
Journal:  Oncotarget       Date:  2017-09-14

10.  Silencing of CARMA3 inhibits bladder cancer cell migration and invasion via deactivating β-catenin signaling pathway.

Authors:  Xiaojun Man; Tao Liu; Yuanjun Jiang; Zhe Zhang; Yuyan Zhu; Zhenhua Li; Chuize Kong; Jiani He
Journal:  Onco Targets Ther       Date:  2019-08-09       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.